Results 91 to 100 of about 49,037 (222)
Synergism of Linezolid and Rifampin to Combat Multidrug-Resistant Environmental Enterococci Isolates
Background and Aim: Wastewater is one of the most dangerous and important sources of pathogens and their treatment does not always guarantee the elimination of pathogenic bacteria.
Mobina Noori +2 more
doaj
ABSTRACT Brigatinib, an oral ALK inhibitor for metastatic NSCLC, lacks dosing guidance for special populations such as the Chinese. This study developed a physiologically based pharmacokinetic (PBPK) model using European data from patients with hepatic/renal impairment and drug–drug interaction (DDI) studies (itraconazole, rifampin). The model was then
Yichao Xu +6 more
wiley +1 more source
Acute Interstitial Nephritis Associated with Intermittent Rifampin Use [PDF]
Rifampin is a widely used antimicrobial agent, most commonly administered in the treatment of tuberculosis. Since its introduction in the late 1960s, rifampin has become a standard agent in the treatment of tuberculosis, especially with the acceptance ...
Edward Lor, Michael D. Katz
core +1 more source
Adequacy of rifampin absorption after jejunostomy tube administration [PDF]
It is not always possible to administer antituberculosis pharmacotherapy orally for reasons that may be a direct consequence of tuberculosis itself. To our knowledge, no published literature is available regarding antituberculosis drug absorption via ...
Mike B.J. Beadsworth +11 more
core +1 more source
Contezolid has activity against methicillin-resistant Staphylococcus aureus (MRSA), a common cause of orthopedic infection. In a rat model of foreign body osteomyelitis, 1.3 log10 cfu/g bone and 0.5 log10 cfu/k-wire reduction in MRSA was found in tibiae (
Sebastian C. Herren +6 more
doaj +1 more source
Fluoroquinolones and rifampin combination in the backdrop of heteroresistant tuberculosis [PDF]
The impact of heteroresistance on tuberculosis (TB) treatment outcomes is unclear, as is the role of different rifampin and isoniazid exposures on developing resistance mutations.
Akkerman, Onno W; id_orcid +9 more
core +1 more source
Felix Greimel,1 Christine Scheuerer,1 Andre Gessner,2 Michaela Simon,2 Thomas Kalteis,1 Joachim Grifka,1 Achim Benditz,1 Hans-Robert Springorum,1 Jens Schaumburger1 1Department of Orthopedics, University Medical Center Regensburg, Asklepios ...
Greimel F +8 more
doaj
Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin [PDF]
Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia.
Khalid Abusaada +2 more
core
Introducción. La tuberculosis es un problema de salud pública a nivel mundial. En 2014, la Organización Mundial de la Salud estimó que se habían presentado 9,6 millones de casos nuevos y 480.000 multirresistentes.
Claudia Llerena +3 more
doaj +1 more source
Consumed by Abdominal Distention
Arthritis Care &Research, Volume 78, Issue 8, Page 959-966, August 2026.
Abimbola Fadairo‐Azinge +3 more
wiley +1 more source

